SLS Deferred Revenue
Sellas Life Sciences Group Inc · Deferred Revenue
SLS Deferred Revenue
Latest reported$0.00period ending
SLS Quarterly Deferred Revenue ($0.00 → $0.00)
Quarterly deferred revenue
High-resolution chart · PNG
SLS deferred revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Deferred Revenue (USD) |
|---|---|
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 900,000 | |
| 5,600,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| -306,000 | |
| -362,000 | |
| -359,000 | |
| 0 | |
| 4,407,000 | |
| 4,668,000 | |
| 5,505,000 | |
| 4,310,000 | |
| 4,486,000 | |
| 3,934,000 | |
| 4,139,000 | |
| 5,242,000 | |
| 3,819,000 | |
| 9,803,000 | |
| 9,042,000 | |
| 30,292,000 | |
| 7,329,000 | |
| 12,923,000 | |
| 12,149,000 | |
| 15,669,000 | |
| 15,292,000 | |
| 11,789,000 | |
| 5,028,000 | |
| 8,667,000 | |
| 7,577,000 | |
| 6,075,000 | |
| 8,407,000 | |
| 1,268,000 | |
| 2,012,000 | |
| 1,478,000 | |
| 3,532,000 | |
| 816,000 | |
| 877,000 | |
| 578,000 | |
| 1,916,000 | |
| 1,113,000 | |
| 1,176,000 | |
| 1,203,000 | |
| 1,226,000 | |
| 1,077,000 | |
| 1,477,000 | |
| -14,000 | |
| -17,000 | |
| 974,000 | |
| 882,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |